RADiCAIT
Techstars '24London, GB · 2 known investors
RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
Founders & leadership
DS
Dr Seán WalshCEO
DR
Dr Regent LeeCMIO
DS
Dr Sina ShahendehCTO
JS
JP SampsonCOO
Investors · 2
In the news
Frequently asked questions
- What does RADiCAIT do?
- RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
- Who are RADiCAIT's investors?
- RADiCAIT's investors include Frontline Ventures, Techstars.
- Where is RADiCAIT headquartered?
- RADiCAIT is headquartered in London, GB.